Open AccessDramatic improvement of severe acne pustolosa after adalimumab in a patient with ulcerative colitis
Author(s) -
Rispo Antonio,
Musto Dario,
Imperatore Nicola,
Testa Anna,
Rea Matilde,
Castiglione Fabiana
Publication year - 2016
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.520
Subject(s) - medicine , ulcerative colitis , adalimumab , acne , azathioprine , refractory (planetary science) , dermatology , rescue therapy , gastroenterology , tumor necrosis factor alpha , disease , physics , astrobiology
Key clinical message A 22‐year‐old male with extensive steroid‐dependent/azathioprine‐refractory ulcerative colitis and preexistent severe refractory acne pustolosa (AP) was successfully treated with adalimumab for both conditions. Severe AP could be considered a further indication, instead of a relative restriction, to anti‐TNFα in steroid‐dependent IBD patients needing therapy with this class of drugs.